ProMIS Neurosciences, Inc. (PMN) Insider Trading Activity

NASDAQ$9.05
Market Cap
$11.83M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
349 of 826
Rank in Industry
195 of 467

PMN Insider Trading Activity

PMN Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$29,524
2
67
Sells
$0
1
33

Related Transactions

Milbury Max A.Principal Accounting Officer
1
$14,929
0
$0
$14,929
Cashman NeilChief Scientific Officer
1
$14,595
0
$0
$14,595
GORDON MICHAEL S10 percent owner
0
$0
1
$0
$0

About ProMIS Neurosciences, Inc.

ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils in MSA. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.

Insider Activity of ProMIS Neurosciences, Inc.

Over the last 12 months, insiders at ProMIS Neurosciences, Inc. have bought $29,524 and sold $0 worth of ProMIS Neurosciences, Inc. stock.

On average, over the past 5 years, insiders at ProMIS Neurosciences, Inc. have bought $1M and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Milbury Max A. (Principal Accounting Officer) — $14,929. Cashman Neil (Chief Scientific Officer) — $14,595.

The last purchase of 30,392 shares for transaction amount of $14,929 was made by Milbury Max A. (Principal Accounting Officer) on 2025‑10‑03.

List of Insider Buy and Sell Transactions, ProMIS Neurosciences, Inc.

2025-10-03PurchaseMilbury Max A.Principal Accounting Officer
30,392
0.1075%
$0.49
$14,929
-18.03%
2025-06-30SaleGORDON MICHAEL S10 percent owner
93,223
–
$0
$0
-9.09%
2025-02-10PurchaseCashman NeilChief Scientific Officer
15,000
0.0458%
$0.97
$14,595
-45.83%
2024-09-24PurchaseShafmaster Madge K.director
70,000
0.2476%
$1.30
$91,028
-43.62%
2024-09-23PurchaseShafmaster Madge K.director
70,000
0.2439%
$1.28
$89,656
-39.59%
2024-09-20PurchaseShafmaster Madge K.director
60,000
0.2042%
$1.25
$75,066
-38.63%
2024-09-17PurchaseGORDON MICHAEL S10 percent owner
16,292
0.0583%
$1.40
$22,809
-41.59%
2024-09-16PurchaseGORDON MICHAEL S10 percent owner
76,931
0.2281%
$1.22
$94,071
-44.36%
2024-08-14PurchaseKirwin Patrick D.director
10,000
0.0536%
$1.25
$12,492
-25.87%
2024-07-31PurchaseTitle 19 Promis10 percent owner
465,116
3.8479%
$2.15
$999,999
-37.11%
2024-07-31PurchaseGORDON MICHAEL S10 percent owner
465,116
3.8479%
$2.15
$999,999
-37.11%
2024-07-31PurchaseSclar Jeremy M.10 percent owner
697,674
5.7719%
$2.15
$1.5M
-37.11%
2023-12-04SaleSclar Jeremy M.10 percent owner
150,000
–
$0
$0
+36.44%
2023-12-04PurchaseSclar Jeremy M.10 percent owner
150,000
–
$0
$0
+36.44%
2022-12-16PurchaseWilliams Eugenedirector
2,000
0.0251%
$4.64
$9,290
-12.90%
2022-12-15PurchaseKirwin Patrick D.director
2,000
0.0278%
$4.51
$9,020
-0.69%
2022-12-14PurchaseFarfel Gail MChief Executive Officer
1,000
0.0136%
$4.94
$4,940
-10.45%
2022-12-13PurchaseKirwin Patrick D.director
1,000
0.0136%
$4.87
$4,870
-9.03%
2022-12-12PurchaseWilliams Eugenedirector
1,000
0.0136%
$5.08
$5,075
-12.50%
2022-12-09PurchaseKirwin Patrick D.director
1,000
0.0133%
$4.98
$4,980
-12.20%
Total: 25
*Gray background shows transactions not older than one year
*Some uncertain data for Preferred Stock share type transactions are shown in italics; for actual data please follow the link

Insider Historical Profitability

<0.0001%
Milbury Max A.Principal Accounting Officer
45389
3.4713%
$410,770.4510
Cashman NeilChief Scientific Officer
16617
1.2708%
$150,383.8510
GORDON MICHAEL S10 percent owner
0
0%
$031
<0.0001%
Title 19 Promis10 percent owner
1575629
120.5007%
$14.26M10
<0.0001%
Sclar Jeremy M.10 percent owner
1467437
112.2264%
$13.28M21
<0.0001%
Shafmaster Madge K.director
208333
15.9329%
$1.89M30
<0.0001%
Williams Eugenedirector
159930
12.2311%
$1.45M50
Kirwin Patrick D.director
62983
4.8168%
$569,996.1550
<0.0001%
Farfel Gail MChief Executive Officer
2000
0.153%
$18,100.0020
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$8,253,997
122
-53.40%
$9.86M
$53,490,060
55
19.35%
$13.53M
$17,168,388
54
-43.55%
$13.15M
$226,127
22
-27.62%
$10.24M
$53,355
19
-41.05%
$11.57M
$37,197,670
19
-48.42%
$10.28M
$112,810,270
18
-1.20%
$15.12M
$112,908,886
15
-2.59%
$15.42M
$1,246,170
12
65.67%
$11.74M
$188,726
11
-28.87%
$10.16M
$4,146,041
11
-40.86%
$12.44M
$11,777,042
10
-11.94%
$11.9M
ProMIS Neurosciences, Inc.
(PMN)
$3,885,120
9
-38.33%
$11.83M
$232,642
8
-8.03%
$10.23M
$7,268,979
7
-48.44%
$10.13M
$2,060,158
5
-21.35%
$10.51M
$31,190
2
-14.18%
$12.52M
$16,750
1
32.10%
$14.45M
$3,750
1
-33.13%
$15.26M

PMN Institutional Investors: Active Positions

Increased Positions13+59.09%242,499+66.8%
Decreased Positions6-27.27%197,433-54.38%
New Positions9New8,772New
Sold Out Positions4Sold Out130,149Sold Out
Total Postitions29+31.82%408,098+12.41%

PMN Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Ally Bridge Group (Ny) Llc$2,242.0012.47%249,340+195,963+367.13%2025-09-30
Armistice Capital, Llc$1,070.005.95%118,981+33,465+39.13%2025-09-30
Sphera Funds Management Ltd.$106.000.59%11,807-64,165-84.46%2025-09-30
Citadel Advisors Llc$61.000.34%6,803+4,266+168.15%2025-09-30
Allostery Investments Lp$56.000.31%6,229-3,119-33.37%2025-06-30
Hrt Financial Lp$24.000.14%2,722+2,722New2025-09-30
Xtx Topco Ltd$24.000.14%2,707+2,707New2025-09-30
Graypoint Llc$19.000.11%2,113+2,113New2025-06-30
Bank Of Montreal /Can/$11.000.06%1,21500%2025-09-30
Fiduciary Trust Co$10.000.06%1,14300%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.